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Objective: To evaluate the antidiabetic and antioxidant effects of aqueous ethanolic
extract of Caesalpinia ferrea (C. ferrea) leaf in normal and streptozotocin (STZ) induced
diabetic rats.
Methods: Male Sprague-Dawley rats divided into 6 groups of 6 rats each were assigned
into diabetic and non-diabetic groups. Diabetes was induced in rats by single intraperi-
toneal administration of STZ (65 mg/kg body weight). C. ferrea extract at the doses of
250 and 500 mg/kg body weight was orally administered to both diabetic and non-
diabetic animals for a period of 30 days. After completion of experimental duration
serum, liver and pancreas were used for evaluating biochemical and histopathological
changes.
Results: Oral administration of C. ferrea leaf extract signiﬁcantly reduced elevated
serum glucose, a-amylase, liver function levels and signiﬁcantly increased serum insulin,
total protein and body weight as well as improved lipid proﬁle due to diabetes.
Furthermore, the treatment resulted in a marked increase in glutathione peroxidase, su-
peroxide dismutase, catalase and reduced glutathione, and diminished levels of lipid
peroxidation in liver and pancreas of diabetic rats. Histopathological studies demonstrated
the reduction in the pancreas and liver damage and conﬁrmed the biochemical ﬁndings.
Conclusions: From the present study, it can be concluded that the C. ferrea leaf extract
effectively improved hyperglycaemia while inhibiting the progression of oxidative stress
in STZ-induced diabetic rats. Hence, it can be used in the management of diabetes
mellitus.1. Introduction
Diabetes mellitus (DM) is a group of metabolic diseases
characterized by abnormal metabolism of carbohydrates, pro-
teins, and fats resulting from inadequate pancreatic insulinsecretion with or without concurrent impairment of insulin ac-
tion [1]. According to the American diabetes association, the
chronic hyperglycemia is associated with long-term damage,
dysfunction, and failure of different organs, especially the eyes,
kidneys, nerves, heart and blood vessels [2]. DM is considered
the most prevalent disease in the world affecting 25% of the
population. It afﬂicts 150 million people and is predicted to
rise to 300 million by 2025 [3]. It is likely to be the ﬁfth
leading cause of death worldwide [4].
Previous studies have demonstrated that DM exhibits
enhanced oxidative stress and highly reactive oxygen species
(ROS) production in pancreatic islets due to persistent and
chronic hyperglycemia, thereby depletes the activity of thean open access article under the CC BY-NC-ND
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generation [5]. Oxygen free radicals have been suggested to be a
contributory factor in complications of DM [6]. It seems to be an
oxidative stress-related disorder and the antioxidants may be
useful in preventing it [7]. Therefore supplementation of
therapeutics with antioxidants may have a chemoprotective
role in diabetes [8].
Many plant extracts and their products have been shown to
have signiﬁcant antioxidant effect in treating many kinds of
diseases [9]. The use of medicinal plants for the treatment of
human diseases has increased considerably worldwide [10].
Ethnopharmacological evidence has shown that the use of
plants is also helpful in prophylaxis or treatment of diabetes.
Given that, herbal medicine possesses signiﬁcant efﬁcacy, low
incidence of side effects, low cost and relative safety [11],
while synthetic anti-diabetic agents can produce serious side
effects, as hypoglycemic coma and disturbances of the liver and
kidneys [12].
The little studied genus Caesalpinia contains more than 500
species of worldwide distribution [13]. Previous studies of
species of this genus reported remarkable biological activities
such as antimicrobial (Caesalpinia bonducella) [14],
antidiabetic (C. bonducella) [15], antimalarial (Caesalpinia
pluviosa) [16], and anti-inﬂammatory (Caesalpinia sappan) [17].
To date, less than 30 species of this genus have been studied
for their phytoconstituents. The metabolites described include
predominantly ﬂavonoid derivatives, steroids, triterpenoids,
and cassane diterpenes [18].
Caesalpinia ferrea (C. ferrea) Martius (Leguminosae),
popularly known as “pau-ferro” or “juca´”, is a large tree
belonging to the Fabaceae family. It is found mainly in the north
and northeast of Brazil. In folk medicine, the tea of the stem bark
of C. ferrea has been used for the treatment of diabetes. In view
of its ethnomedicinal importance, the Brazilian Ministry of
Health has included this species on the national list of medicinal
plants important to the health system [19].
The pharmacological properties of C. ferrea fruits or stem
barks include antiulcerogenic [20], anti-inﬂammatory [21],
analgesic [22], antibacterial [23], antihypertensive [24],
antidiabetic [19], and cancer chemopreventive [25] activities.
Recently a unique chalcone trimer (pauferrol A) and two
chalcone dimers (pauferrol B and pauferrol C), were isolated
from the stems of C. ferrea. These chalcones exhibited potent
inhibitory activities against topoisomerase II [26,27]. The leaves
contain three formerly unknown di-O-glycosyl-C-glucosyl ﬂa-
vones which were isolated, puriﬁed and identiﬁed namely: Iso-
vitexin 200-O-b-[xylopyranosyl-(10000/200)-O-b-xylopyranosyl];
Vitexin 200-O-b-[xylopyranosyl-(10000/200)-O-b-xylopyranosyl];
Orientin 200-O-b-[xylopyranosyl-(10000/200)-O-b- xylopyranosyl
[28]. However, there is no experimental evidence proving
biological activities of C. ferrea leaf up till now. Therefore,
the present study was aimed to evaluate the possible
hypoglycemic properties of C. ferrea leaf in streptozotocin
(STZ) induced diabetic rats.
2. Materials and methods
2.1. Chemicals
STZ, reduced glutathione, 5,5’-dithiobis (2-nitrobenzoic
acid) (DTNB), 1-chloro 2,4-dinitrobenzene (CDNB) and 2,2-
diphenyl-1-picrylhydrazyl (DPPH) were purchased fromSigma–Aldrich (St. Louis, MO, USA). Metaphosphoric acid
(MPA) and nitroblue tetrazolium were purchased from Fluka
(Switzerland), and pyrogallol from Merck (Germany). All
chemicals were of analytical grade.
2.2. Plant material
Leaves of C. ferrea were collected from a tree cultivated in
the Zoological Garden, Cairo, Egypt, in May 2012. The plant
was identiﬁed by Prof. Salwa Quashti, National Research Centre
(NRC), Cairo, Egypt. A voucher specimen (C253) has been
deposited at the herbarium of the NRC.
2.3. Plant extraction and isolation
Leaves (2.5 kg), dried in the shadow, were crushed and
exhaustively extracted with 70% (v/v) aqueous EtOH under
reﬂux (three times, each extraction for 8 h with 2 L). The ob-
tained eluent was dried under vacuum at 55–60 C to give
200 g aqueous ethanolic extract that was used in the present
study.
2.4. Phytochemical screening
This aqueous ethanol extract of C. ferrea was screened for
the presence of various phytoconstituents such as steroids, al-
kaloids, glycosides, ﬂavonoids, carbohydrates, amino acids, sa-
ponins, terpenoids, tannins, and phenolic compounds as
described by Dawang & Datup and Mythili & Ravindhran
[29,30].
2.5. Determination of the scavenging of DPPH radical
The quantitative DPPH assay was carried out according to
the method of Kedare and Singh [31]. The extract was
dissolved in a concentration of 1 mg/mL in ethanol. From
this stock solution, concentrations of regular dilution were
prepared. Then 500 mL of sample, 375 mL ethanol and
125 mL of 1 mmol/L prepared DPPH solution were placed
together. The test was performed in triplicate. All samples
were incubated in sequence for 30 min in the dark at room
temperature and their absorbance was measured at a
wavelength of 517 nm on UV–vis spectrophotometer
(Shimadzu, Duisburg, Germany). Ascorbic acid was used as
positive control. Percentage of radical scavenging activity
(RSA) was calculated as follows:
RSA% = [(Abs of control – Abs of sample)/Abs of blank] × 100
2.6. Acute toxicity study
The mean lethal dose (LD50) of the aqueous ethanolic extract
of C. ferrea leaf was determined in rats (weighing 180–200 g)
using the method described by Chinedu et al. [32].
2.7. Experimental animals
Male Sprague-Dawley rats weighting 180–200 g were pur-
chased from the Animal House of National Research Centre,
Egypt. Animals were acclimated for a period of 7 days in our
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fed with standard laboratory diet and allowed to drink water ad
libitum under well ventilated conditions of 12 h light/dark cy-
cles. Experimental protocols for the animal studies were carried
out in accordance with Institutional Ethical Guidelines for the
care of laboratory animals of the National Research Centre.
2.8. Induction of diabetes
Diabetes was induced in overnight fasted rats by a single
intraperitoneal (i.p.) injection of a freshly buffered (0.1 mol/L
citrate, pH 4.5) solution of STZ at a dosage of 65 mg/kg body
weight. After 72 h of STZ administration, the tail vein blood was
collected to determine fasting blood glucose level with an Accu-
Chek sensor comfort glucometer (China). Only rats with hy-
perglycemia (glucose over 250 mg/dL) were considered diabetic
and included in the experiment.
2.9. Experimental design
Rats were randomly divided into six groups, comprising six
rats each. The treatment schedule was as follows:
Group I: normal control (NC); Group II: C. ferrea leaf extract
(500 mg/kg body weight) treated normal rats (CF500-NC);
Group III: C. ferrea leaf extract (250 mg/kg body weight) treated
normal rats (CF250-NC); Group IV: diabetic control (DC);
Group V: C. ferrea leaf extract (500 mg/kg body weight) treated
diabetic rats (CF500-DC); Group VI: C. ferrea leaf extract
(250 mg/kg body weight) treated diabetic rats (CF250-DC).
Different doses of C. ferrea aqueous ethanolic extract were
administered orally using an intragastric tube daily to the
respective group till the end of the experiment. All doses were
started 72 h after STZ injection.
2.10. Blood and tissue sampling
At the end of the 30-day experiment (after diabetes induction),
overnight fasting animals were ether anaesthetized. Venous retro
orbital blood samples were collected using a glass capillary
without anticoagulant. Serum was separated by centrifugation at
3000 r/min for 15 min. The resulting samples were stored at
−20 C until assayed. Liver and pancreas were removed and
washed in ice-cold saline solution immediately, and then each
organ was divided into two portions. A portion was homogenized
in 0.1 mol/L potassium phosphate buffer (pH 7.4) using Tissue
master TM125 (Omni International, USA). After centrifugation at
3000 r/min for 10 min, the clear supernatant was stored at −80 C
to be used for biochemical analysis. The other portion of the liver
and pancreas was ﬁxed in 10% formalin for histological analysis.
2.11. Biochemical analysis
2.11.1. Determination of serum glucose, insulin and a-
amylase
Blood glucose was determined using Biodiagnostic kit,
Egypt. Insulin level was estimated with sandwich immunolu-
minometric assay kit supplied from Snibe Co., Ltd., China using
Maglumi 1000 fully automated chemiluminescence immuno-
assay analyzer (Snibe Co.,Ltd., China). Alpha-amylase activity
was assayed using kits supplied by ELitech Clinical Systems,
France.2.11.2. Determination of serum lipid proﬁle
Serum concentrations of triglyceride (TG), total cholesterol
(TC), and high-density lipoprotein cholesterol (HDL-C) were
determined using commercially available kits supplied by
Reactivos GPL, Spain. Low-density lipoprotein cholesterol
(LDL-C) was calculated according to Friedewald's formula
[33]:
LDL = [(TC − HDL) − TG/5]
2.11.3. Determination of serum liver function
Serum aspartate transaminase (AST) and alanine trans-
aminase (ALT) were assayed using kits provided by Biorexfars,
UK. Serum alkaline phosphatase (ALP) was estimated using kits
supplied by Stanbio, USA, whereas serum glutamyl trans-
peptidase (GGT) and serum total protein (TP) were measured
using kits supplied by Reactivos GPL, Spain and Biodiagnostic,
Egypt respectively.
2.11.4. Determination of oxidative stress markers in
hepatic and pancreatic tissue
Glutathione peroxidase activity (GSH-Px) was measured
according to the method of Necheles et al. [34]. Superoxide
dismutase activity (SOD) was investigated utilizing the
technique of Minami and Yoshikawa [35]. Catalase (CAT)
activity was determined by the method of Aebi [36]. Lipid
peroxidation was estimated colorimetrically by measuring
thiobarbituric acid reactive substances (TBARS) according
to method of Lefe`vre et al. [37]. Reduced glutathione
(GSH) was estimated according to the method of Beutler
et al. [38] after precipitating liver and pancreas proteins
with 10% MPA.
2.11.5. Histopathological investigation
The histopathologic examination was performed by light
microscopy on liver and pancreas specimens that were ﬁxed in
10% formalin. After ﬁxation, the samples were processed to
obtain 5 mm thick parafﬁn sections. Pancreas and liver sections
were stained with hematoxilin and eosin (H & E). Then the
slides were observed under a Leica photomicroscope.
2.11.6. Image morphometry
The morphometric analysis was performed at the Pathol-
ogy Department, National Research Center using the Leica
Qwin 500 Image Analyzer (LEICA Imaging Systems Ltd.,
Cambridge, England) which consists of Leica DM-LB mi-
croscope with JVC color video camera attached to a com-
puter system Leica Q 500IW. The morphometric analysis is
carried out on H & E stained slides. The slides to be
examined were placed on the stage of the microscope, and
focused it at low power magniﬁcation (100×). We screen the
slide to determine the boundaries of the tissue to be
measured. The condenser is centered and focused, and the
light source is set to the required level. Successful adjustment
of illumination is checked for on the video monitor. The area
of Langerhans islets were measured by drawing a line starting
from one edge to the other and from one edge till the
opposite, respectively. The results appear automatically on
the monitor in the form of square micron (mm2) with the
mean and standard error.
Table 2
Changes of the body weight of rats during the experimental period of 30
days.
Groups Initial body weight (g) Final body weight (g)
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Data were expressed as mean ± SEM. The statistical signif-
icance was evaluated by One-way analysis of variance
(ANOVA) using SPSS-14 statistical software followed by LSD
test to detect differences between groups. The differences were
considered statistically signiﬁcant at P < 0.05.
3. Results
3.1. Phytochemical screening of C. ferrea extract
The preliminary phytochemical screening of C. ferrea
aqueous ethanolic extract indicated the presence of carbohy-
drates, glycosides, tannins, and phenolic compounds as shown in
Table 1.Table 1
Phytochemical screening of aqueous ethanolic extract of C. ferrea leaf.
Phytochemicals Presence/absence
Carbohydrates and/or glycosides Present
Tannins Present
Saponins Absent
Alkaloids Absent
Anthraquinones Absent
Unsaturated sterols or triterpenes Absent
Phenolic compounds Present
I) NC 185.00 ± 3.41 235.44 ± 6.24
II) CF500-NC 181.33 ± 1.74 230.92 ± 7.19b
III) CF250-NC 198.33 ± 4.01 235.50 ± 10.17b
IV) DC 190.00 ± 4.47 182.33 ± 5.67a
V) CF500-DC 183.66 ± 2.07 218.00 ± 4.53b
VI) CF250-DC 189.83 ± 3.74 198.70 ± 6.68a
Data are expressed as mean ± SEM (n = 6). Values with different su-
perscripts down the column are signiﬁcantly different at P < 0.05.
a Statistically different from NC group.
b Statistically different from DC group.
Table 33.2. Radical scavenging activity of C. ferrea extract
During evaluation of the antioxidant activity, the aqueous
ethanol extract of C. ferrea exhibited a remarkable radical
scavenging activity in the DPPH assay. Figure 1 demonstrates
this effect quantitatively in comparison to those of ascorbic acid.
The antioxidant capacity of the extract (ED50) was determined to
be (12.45 ± 2.86) mg/mL.
3.3. Acute toxicity
Acute toxicity studies revealed the non-toxic nature of
C. ferrea aqueous ethanolic extract as the treated rats appeared
normal and did not display any signiﬁcant changes in behavior
or neurological responses up to 1500 mg/kg body weight of the
extract. There was no mortality or toxicity reaction at any of the
doses until the end of the study.Figure 1. Antioxidant capacity of the aqueous ethanolic extract of
C. ferrea leaf (DPPH assay).3.4. Effect of C. ferrea extract on body weight
As shown in Table 2, body weights of rats in DC group were
lower than those in other groups. STZ caused a signiﬁcant
weight loss of rats in DC and CF250-DC groups in comparing to
NC group, while treatment with C. ferrea extract at 500 mg/kg
body weight to diabetic rats signiﬁcantly suppressed such
decrease in the body weight. No signiﬁcant difference was
observed after treatment with C. ferrea extract in CF250-DC as
compared to the DC group.3.5. Effect of C. ferrea extract on blood glucose, insulin
and a-amylase
As shown in Table 3, serum glucose levels of DC and CF-DC
groups were signiﬁcantly increased as compared to NC group.
The administration of C. ferrea extract to STZ-induced diabetic
rats in groups CF500-DC and CF250-DC signiﬁcantly reduced
serum glucose levels as compared to the DC group. Whereas,
serum insulin levels of DC and CF250-DC groups signiﬁcantly
decreased as compared to NC group. The administration of 500
and 250 mg/kg of C. ferrea extract to diabetic rats signiﬁcantly
increased insulin level as compared to the DC group and nearly
returned to the basal level in a dose-dependent manner. More-
over, a-amylase activity in the DC and CF-DC groups were
signiﬁcantly higher than those in the normal NC group. The
administration of C. ferrea extract to diabetic rats in CF500-DCSerum glucose, insulin, and a-amylase values in all groups.
Groups Glucose
(mg/dL)
Insulin
(mIU/mL)
a-amylase
(IU/L)
I) NC 102.14 ± 3.87 2.80 ± 0.25 15.04 ± 0.68
II) CF500-NC 95.86 ± 2.99b 3.07 ± 0.20b 16.75 ± 0.97b
III) CF250-NC 96.84 ± 2.66b 2.92 ± 0.18b 14.85 ± 0.66b
IV) DC 388.49 ± 19.00a 1.23 ± 0.05a 249.50 ± 15.83a
V) CF500-DC 121.60 ± 5.32a,b 2.47 ± 0.13b 153.83 ± 4.98a,b
Change from
DC (%)
68.60% 101.6% 38.34%
VI) CF250-DC 134.50 ± 8.76a,b 2.02 ± 0.10a,b 174.71 ± 6.63a,b
Change from
DC (%)
65.37% 64.48% 29.97%
Data are expressed as mean ± SEM (n = 6). Values with different su-
perscripts down the column are signiﬁcantly different at P < 0.05.
a Statistically different from NC group.
b Statistically different from DC group.
Table 4
Effect of C. ferrea extract on serum lipid proﬁle in all groups.
Groups TG (mg/dL) TC (mg/dL) HDL-C (mg/dL) LDL-C (mg/dL)
I) NC 48.39 ± 1.89 52.05 ± 1.57 28.71 ± 0.80 13.77 ± 1.23
II) CF500– NC 48.14 ± 1.93b 47.47 ± 1.43b 27.54 ± 0.96b 10.28 ± 0.98b
III) CF250– NC 28.46 ± 1.92a,b 46.74 ± 1.37b 29.62 ± 0.97b 11.43 ± 1.04b
IV) DC 108.17 ± 6.37a 99.59 ± 5.44a 18.36 ± 0.63a 59.60 ± 5.23a
V) CF500- DC 49.35 ± 1.36b 58.91 ± 2.63b 25.20 ± 1.40a,b 22.27 ± 2.28a,b
Change from DC (%) 54.37% 40.84% 37.25% 62.63%
VI) CF250- DC 61.14 ± 2.82a,b 56.38 ± 1.46b 24.41 ± 1.10a,b 21.32 ± 1.37a,b
Change from DC (%) 43.47% 43.38% 32.95% 64.22%
Data are expressed as mean ± SEM (n = 6). Values with different superscripts down the column are signiﬁcantly different at P < 0.05.
a Statistically different from NC group.
b Statistically different from DC group.
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tivity as compared to the DC group.
3.6. Effect of C. ferrea extract on lipid proﬁle
Table 4 shows the levels of serum lipid proﬁle of rats in
different experimental groups. Rats in DC group displayed a
signiﬁcant increase in the levels of TG, TC, and LDL-C in
comparison with NC group. However, serum HDL-C level of
rats in DC group was signiﬁcantly lower than that of rats in NC
group. Treatment with C. ferrea extract in CF500-DC and
CF250-DC groups showed a signiﬁcant decrease in the levels of
serum TG, TC, and LDL-C and simultaneous signiﬁcant in-
crease in the level of HDL-C when compared with DC group.
Although the serum HDL-C and LDL-C level did not return to
the basal level of NC group, the serum TG level in CF500-DC
group and TC level in both CF500-DC and CF250-DC groups
were able to return.
3.7. Effect of C. ferrea extract on serum liver function
The data for serum liver function tests are presented in
Table 5. Serum activities of AST, ALT, ALP, and GGT bio-
markers of liver toxicity were signiﬁcantly elevated in STZ
induced diabetic rats when compared to normal controls.
Treatment of diabetic rats with 500 and 250 mg/kg of C. ferrea
extract signiﬁcantly reduced the activity of these biomarkers
with respect to diabetic control rats for both doses. Such
reduction nearly returned to the basal normal level for AST and
ALT activities but ALP and GGT could not return. On the
contrary, serum level of TP was signiﬁcantly decreased in DCTable 5
Effect of C. ferrea extract on the activity of liver enzymes and total protein
Groups AST (IU/L) ALT (IU/L)
I) NC 44.00 ± 2.61 44.67 ± 1.93
II) CF500- NC 45.66 ± 1.52b 43.92 ± 1.20b
III) CF250- NC 46.16 ± 1.82b 49.66 ± 1.91b
IV) DC 80.50 ± 3.33a,b 59.33 ± 1.89a
V) CF500- DC 50.16 ± 3.71b 46.50 ± 1.43b
Change from DC (%) 37.68% 21.62%
VI) CF250- DC 51.66 ± 4.96b 47.83 ± 1.90b
Change from DC (%) 35.82% 19.38%
Data are expressed as mean ± SEM (n = 6). Values with different superscri
a Statistically different from NC group.
b Statistically different from DC group.group as compared to normal control rats. Administration of 500
and 250 mg/kg of C. ferrea extract for diabetic rats signiﬁcantly
increased TP level and adjusted to the normal level.
3.8. Effect of C. ferrea extract on hepatic and pancreatic
oxidative stress markers
Table 6 reveals a signiﬁcant decrease in antioxidant enzyme
activities (GSH-Px, SOD, CAT) and antioxidant GSH level. A
signiﬁcant elevation in TBARS production was observed in the
hepatic and pancreatic tissues of rats in DC group when
compared with NC group. C. ferrea extract treatment of diabetic
rats in CF500-DC and CF250-DC groups signiﬁcantly raised
GSH-Px, SOD & CAT enzyme activities and GSH level and
inhibited the formation of TBARS as compared to DC group in a
dose-dependent manner. Though, such improvement in GSH
and TBARS levels did not restore to basal level of NC group,
while GSH-Px, SOD and CAT enzyme activities returned to
normal basal values in CF500-DC.
3.9. Effect of C. ferrea extract on pancreas and liver
histopathological examination
The histological investigation of pancreas showed normal
architecture in case of NC, CF500-NC and CF250-NC groups.
The endocrine portions of pancreas or islets of Langerhans were
present in the pancreatic tissue featured circular shapes with
normal cell lining, while the exocrine components that included
acini appeared well organized and with normal morphology. The
interlobular duct was surrounded with the supporting tissue
(Figure 2A–C). The image analyzer results showed that thein all groups.
ALP (IU/L) GGT (IU/L) TP (g/dL)
23.24 ± 1.52 1.57 ± 0.16 5.55 ± 0.05
25.36 ± 1.54b 1.40 ± 0.18b 5.70 ± 0.10b
26.86 ± 1.17b 1.64 ± 0.05b 5.65 ± 0.18b
56.77 ± 2.03a 3.30 ± 0.38a 4.85 ± 0.18a
36.77 ± 2.28a,b 2.54 ± 0.22a,b 5.73 ± 0.21b
35.22% 23.03% 18.14%
37.63 ± 1.86a,b 2.57 ± 0.21a,b 5.53 ± 0.14b
33.71% 22.12% 14.02%
pts down the column are signiﬁcantly different at P < 0.05.
Table 6
Effect of C. ferrea extract on oxidative stress markers of liver and pancreas in all groups.
Groups GSH-Px (IU/g tissue) SOD (IU/g tissue) CAT (IU/mg tissue) GSH (mg%) TBARS (nmol/mg tissue)
Liver
I) NC 74.11 ± 1.54 99.37 ± 2.53 16.12 ± 0.67 12.09 ± 0.91 14.16 ± 0.92
II) CF500- NC 83.10 ± 1.93b 116.13 ± 1.67b 18.90 ± 0.78b 13.24 ± 0.87b 13.67 ± 0.74b
III) CF250- NC 76.94 ± 1.28b 102.53 ± 5.33b 17.89 ± 0.57b 11.70 ± 1.30b 14.78 ± 0.57b
IV) DC 59.70 ± 2.74a 73.40 ± 3.45a 10.72 ± 0.57a 1.20 ± 0.30a 25.74 ± 0.24a
V) CF500- DC 71.63 ± 1.12b 93.06 ± 2.93b 16.21 ± 0.65b 7.68 ± 2.26a,b 16.81 ± 0.45a,b
Change from DC (%) 19.98% 26.78% 51.21% 540% 34.69%
VI) CF250- DC 67.29 ± 1.13a,b 84.40 ± 2.27a,b 14.37 ± 0.61b 7.11 ± 1.68a,b 19.36 ± 0.28a,b
Change from DC (%) 12.71% 14.98% 34.04% 492.5% 24.78%
Pancreas
I) NC 54.74 ± 1.84 67.28 ± 2.94 2.57 ± 0.17 4.29 ± 0.46 6.22 ± 0.47
II) CF500- NC 62.63 ± 1.87b 71.70 ± 3.19b 3.06 ± 0.22b 4.97 ± 0.47b 5.52 ± 0.54b
III) CF250- NC 58.53 ± 2.25b 64.69 ± 1.97b 2.89 ± 0.25b 4.44 ± 0.23b 4.72 ± 0.38a,b
IV) DC 41.85 ± 2.36a 43.63 ± 2.35a 0.68 ± 0.08a 0.37 ± 0.02a 13.22 ± 0.15a
V) CF500- DC 52.72 ± 1.98b 62.86 ± 2.54b 2.37 ± 0.16b 1.71 ± 0.16a,b 8.67 ± 0.43a,b
Change from DC (%) 25.97% 44.07% 284.52% 362.16% 34.41%
VI) CF250- DC 48.89 ± 2.14b 56.26 ± 1.99a,b 2.06 ± 0.17b 1.32 ± 0.13a,b 9.59 ± 0.32a,b
Change from DC (%) 16.82% 28.94% 202.94% 256.75% 27.45%
Data are expressed as mean ± SEM (n = 6). Values with different superscripts down the column are signiﬁcantly different at P < 0.05.
a Statistically different from NC group.
b Statistically different from DC group.
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whereas for CF500-NC and CF250-NC groups were
(191.23 ± 1.05) and (171.17 ± 2.02) mm2, respectively.
In case of pancreas of diabetic rats, histopathological exam-
ination of pancreas showed the acinar cells around the islets
though seemed to be in normal proportion did not look classical.
The cells of islets were in degenerative form with asymmetrical
vacuoles. Intra islets hemorrhage was also seen (Figure 2D and
E). A signiﬁcant reduction in the number of b-cells and size of
islet cells was detected. The mean islets area of the diabetic rats
was (122.93 ± 15.13) mm2. These indicate it appeared smaller in
comparison with normal rats.
Microscopic investigation of pancreas sections of CF500-DC
and CF250-DC groups revealed regeneration and restoration of
size of Langerhans’ islets along with b–cells repair (Figure 2F
and G), suggesting a protective effect on the islets. This recoveryFigure 2. The histological investigation of pancreas. A, B, C: Pancreas sectio
staining acinar cells and a light-staining islet of Langerhans just right of the c
lets though seemed to be in normal proportion did not look classical. The islet is
showing degenerative islet of Langerhans (asterisk) associated with different siz
showing the exocrine pancreas appearing more or less as control. Few degenerat
that appeared relatively larger than the control one. Exocrine pancreas appeareof the b-cell was more evident at higher dose, whereas the mean
of islets area for CF500-DC and CF250-DC groups were
(196.33 ± 14.55) and (192.12 ± 5.22) mm2, respectively.
The microscopic examinations of sections of liver of NC,
CF500-NC and CF250-NC groups showed the normal structure
of the hepatic lobule. The central vein is surrounded by the
hepatocytes with eosinophilic cytoplasm and distinct nuclei. The
hepatic sinusoids were shown between the hepatocytes
(Figure 3A–C). Microscopic examination of liver of DC rats
indicated congestion in the portal tract that was associated with
necrosis of the hepatocytes that surrounded it and moderated
inﬂammatory inﬁltration. Some of the nuclei of the hepatocytes
revealed pyknotic form (Figure 3D). In CF500-DC rats, the
hepatic lobule appeared more or less like control. The activated
Kupffer cells in the sinusoids were seen (Figure 3E). In some
rats congested portal tract associated with necrosis of thens of NC, CF500-NC and CF250-NC groups respectively, showing dense-
anter of the ﬁeld; D: Diabetic rat showing the acinar cells around the is-
shrunken and associated with intra islet hemorrhage (arrow). E: Diabetic rat
e of vacuoles (long arrow) and hemorrhage (short arrow); F: CF500-DC rat
ive cells are seen in the islet. G: CF250-DC rat showing islet of Langerhans
d more or less as control (H & E, Scale bar: 20 mm).
Figure 3. The microscopic examinations of sections of liver of NC, CF500-NC and CF250-NC groups. A, B, C: Liver sections of NC, CF500-NC and
CF250-NC groups, respectively, showing the normal architecture of a hepatic lobule and hepatocytes; D: Diabetic group showing congested portal tract that
is associated with necrosis of the hepatocytes that surround it and moderate inﬂammatory inﬁltration. Some of the nuclei of the hepatocytes are pyknotic. E:
CF500-DC rat showing hepatic lobule that appears more or less like control. Notice the activated Kupffer cells. F: CF500-DC rat showing congested portal
tract that is associated with necrosis of the hepatocytes that surround it and moderate inﬂammatory inﬁltration. G: CF250-DC rat showing the hepatocytes
appearing more or less as the control; H: CF250-DC rat showing mild congestion of the portal tract that is associated with few inﬂammatory inﬁltrations (H
& E, Scale bar: 20 mm).
Sherien Kamal Hassan et al./Asian Pac J Trop Biomed 2015; 5(6): 462–471468hepatocytes that surrounded it and moderated inﬂammatory
inﬁltration were found (Figure 3F). In CF250-DC rats, the liver
examination showed that the hepatocytes appeared more or less
as the control (Figure 3G), while in some cases mild congestion
of the portal tract associated with few inﬂammatory inﬁltration
was seen (Figure 3H).
4. Discussion
Diabetes mellitus is currently a major public health concern,
because its incidence and prevalence are elevated and
increasing, reaching epidemic proportions [39]. Cumulative
evidence has shown that poorly and erratically controlled
hyperglycemia produces abnormally high levels of ROS [40],
and these reactive substances could react with essential
molecules such as lipids, proteins and DNA, leading to
histological changes as well as functional alterations [41]. STZ
is a toxin frequently used to induce diabetes in experimental
animals through its ability to induce selective destruction of
pancreatic beta cells resulting in insulin deﬁciency and
hyperglycemia [42]. To the best of our knowledge, this is the
ﬁrst report that analyzes hypoglycaemic effect of C. ferrea
leaf aqueous ethanolic extract on STZ induced experimental
diabetes.
In the present study, reduction in body weight in diabetic rats
was observed which might be the result of degradation of
structural proteins due to unavailability of carbohydrates for
utilization as an energy source [43,44]. These results agree with
previous observations that have also reported loss of body
weight [45,46]. A signiﬁcant increase was observed in body
weight of diabetic rats treated with C. ferrea extract (CF500-
DC group) as compared to diabetic group which indicates the
preventive effect of the extract on degradation of structural
proteins.
The diabetic rats were found to have higher glucose level and
lower level of insulin when compared to normal control rats.
From the results of the present experiment, it was observed that
treatment with C. ferrea extract decreased the serum glucose andincreased serum insulin in STZ induced diabetic rats (CF-DC
groups). It is perhaps due to stimulation of insulin secretion from
remnant pancreatic b-cells, which in turn enhances glucose
utilization by peripheral tissues of diabetic rats either by pro-
moting glucose uptake and metabolism, or by inhibiting hepatic
gluconeogenesis [47]. This is conﬁrmed by histopathological
observations which show that the structural integrity of islets
of Langerhans was restored towards normalization.
Alpha-amylase is one of the main enzymes in human body
that is responsible for the breakdown of starch to more simple
sugars. a-amylases hydrolyze complex polysaccharides to pro-
duce oligosaccharides and disaccharides which are then hy-
drolyzed by a-glycosidase to monosaccharides which are
absorbed through the small intestines into the hepatic portal
vein and increase postprandial glucose levels [48]. In our
investigation, a signiﬁcant increase in a-amylase was
observed in diabetic rats as compared to control. This result
is in agreement with Adaramoye [49]. Treatment with
C. ferrea extract in CF500-DC and CF250-DC groups moder-
ately inhibited a-amylase. In our phytochemical screening, we
have proved the presence of phenolic compounds in C. ferrea
extract. Some phenolic compounds are known to inhibit the
activity of carbohydrate hydrolyzing enzymes like a-amylase
and a-glucosidase [50].
In diabetes, hyperglycemia is accompanied with dyslipidemia
representing risk factor for coronary heart diseases. The abnormal
high level of serum lipids is mainly due to the uninhibited actions
of lipolytic hormones on the fat depots, mainly due to the action
of insulin. Under normal circumstances, insulin activates the
enzyme lipoprotein lipase, which hydrolyzes TGs. However, in
diabetic state lipoprotein lipase is not activated due to insulin
deﬁciency, resulting in hypertriglyceridemia, and insulin deﬁ-
ciency is also associated with hypercholesterolemia due to
metabolic abnormalities [51]. TGs stimulate the secretion of very
low-density lipoprotein cholesterol and such increase in very
low-density lipoprotein cholesterol particles reduces the HDL-C
level and increases the LDL-C particles [52]. The characteristic
features of diabetic dyslipidemia are increase in serum TG, TC,
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serum lipid proﬁle was found in diabetic rats. This ﬁnding is in
correlation with the ﬁndings of Pepato et al. and Sharma et al.
[54,55]. This altered serum lipid proﬁle was reversed towards
normal after administration of C. ferrea extract with both doses.
Thus, the extract could be helpful in improving lipid
metabolism which will in turn help to prevent diabetic
complications such as coronary heart diseases and atherosclerosis.
It has been well established that elevated levels of AST, ALT
and ALP are indicative of cellular leakage and loss of functional
integrity of the hepatic cell membranes implying hepatocellular
damage [56]. In the present study, the injection of STZ induces
hepatocellular damage, which is one of the characteristic
changes in diabetes as evidenced by high serum levels of
AST, ALT, ALP and GGT in diabetic group compared to the
normal control, suggesting possible damage to the liver. Liver
damage in diabetic rats was conﬁrmed. However, diabetic
groups treated with C. ferrea extract in CF500-DC and
CF250-DC groups showed a signiﬁcant reduction in the levels
of these enzymes when compared to the diabetic untreated
control, which consequently alleviated the damage caused by
STZ as conﬁrmed by hepatocytes morphology. This means that
C. ferrea has some hepatoprotective potentials in diabetic rats by
decreasing serum AST, ALT, ALP and GGT levels. Treatment
of normal rats with C. ferrea in CF500-NC and CF250-NC
groups maintained the levels of serum AST, ALT, ALP and
GGT thereby showing its non-toxic nature.
Under condition of severe oxidative stress, free radical gen-
eration leads to protein modiﬁcation. Proteins may be damaged
directly by speciﬁc interactions of free radicals with particular
susceptible amino acids [57]. The ﬁnding of our study revealed a
signiﬁcant decrease in the level of serum TP in diabetic rats.
This could be due to increased peroxidation. On the other
hand, C. ferrea treated rats showed increased level of TP,
suggesting that C. ferrea extract has antioxidant capacity.
Oxidative stress is suggested as mechanism underlying dia-
betes and diabetic complications, which results from an imbal-
ance between radical generating and radical scavenging systems
[6]. Antioxidant enzymes as well as nonenzymatic antioxidants
are ﬁrst line of defense against ROS induced oxidative
damage in a living organism [58]. SOD, CAT and GSH-Px are
the three major scavenging enzymes that remove the toxic free
radicals in vivo [7]. SOD protects tissues against oxygen free
radicals by catalyzing the removal of superoxide radical,
converting it into H2O2 and molecular oxygen, which both
damage the cell membrane and other biological structures.
CAT is a haemprotein, which is responsible for the
detoxiﬁcation of signiﬁcant amounts of H2O2 [59]. GSH-Px
plays a central role in the catabolism of H2O2 and the
detoxiﬁcation of endogenous metabolic peroxides and
hydroperoxides, which catalyzes GSH [60]. Glutathione
functions as a free radical scavenger and is an essential co-
substrate for GSH-Px [61].
The decreased activity of antioxidant (GSH-Px, SOD and
CAT) enzymes along with decreased GSH level was found in
the liver and pancreatic tissues of diabetic rats. These results are
in agreement with Cheng et al. [62]. It was suggested that
decreased antioxidant enzyme activity in DC group could be
due to glycation of these enzymes, which occurred at
persistently elevated blood glucose levels [63]. However,
administration of C. ferrea extract in CF500-DC, CF250-DCgroups increased the GSH-Px, SOD and CAT activities and
GSH level in the liver and pancreas of diabetic rats.
Lipid peroxidation is one of the characteristic features of
chronic diabetes. The increased free radicals produced may react
with polyunsaturated fatty acids in cell membranes leading to
lipid peroxidation. Lipid peroxidation will in turn result in the
elevated production of free radicals [64]. In the present study, it
was observed that TBARS level in liver and pancreas of STZ-
induced diabetes was signiﬁcantly increased when compared
to the control. The decreased activity of antioxidant molecules
along with elevated TBARS level in diabetic rats could probably
be associated with oxidative stress and decreased antioxidant
defense potential [7]. Diabetic rats treated with C. ferrea extract
in CF500-DC, CF250-DC groups showed decreased level of
TBARS.
Robertson et al. demonstrated that antioxidants have been
shown to break the worsening of diabetes by improving b-cells
function in animal models and suggested that enhancing anti-
oxidant defense mechanisms in pancreatic islets may be a
valuable pharmacologic approach to managing diabetes [65].
In the present study, the biochemical ﬁndings observed in
diabetic rats are in conformity with histopathological alterations
of b-cells of pancreas and hepatocytes. Such histopathological
alterations were reduced by administration of C. ferrea extract at
both doses.
It can be concluded that the aqueous ethanolic extract of
C. ferrea leaf has potential antihyperglycemic activity in STZ
induced diabetic rats. In this sense, the antidiabetic effect may be
due to the presence of secondary metabolites like phenols and
ﬂavonoids in the C. ferrea leaf extract which are responsible for
antioxidant actions and have been found to be beneﬁcial in
controlling diabetes as evident from earlier studies. The three
new phenolic compounds (isovitexin, vitexin and orientin de-
rivatives) isolated in a previous study showed high antioxidant
properties (results not shown) and may contribute to the major
antioxidant activity of the C. ferrea leaf extract [28].
Experimental evidence obtained from this study is encouraging
enough to warrant further studies on the leaf extract of this
plant to ﬁnd out its mechanism of action and to establish its
therapeutic potential in the prophylaxis and/or treatment of
diabetes and diabetic complications.
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